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Thrombospondin-1 induces matrix
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New Haven, Conn
Introduction: Thrombospondin-1 (TSP-1), an extracellular matrix (ECM) glycoprotein, is associated with a variety of
cellular processes relevant to atherosclerosis and intimal hyperplasia, including vascular smooth muscle cell (VSMC)
migration. Matrix metalloproteinase-2 (MMP2) is associated with basement membrane and ECM degradation, impor-
tant processes for cell migration. We hypothesized that TSP-1 modulates MMP2 activity in VSMCs and is critical for
VSMC migration.
Methods: Quiescent bovine aortic VSMCs (48 hours) were incubated in serum-free media (SFM) with or without TSP-1
(10 or 20 g/mL). Gelatinase activity was measured with zymography to determine pro-MMP2 and MMP2 activity.
MMP2 messenger RNA expression was determined with Northern blot analysis. Invasion assays were performed. A
binding assay was used to determine the specificity of TSP-1 binding to MMP2. Blots were quantified with densitometry,
and all comparisons were made with a paired t test.
Results: TSP-1 induced production of activated forms of MMP2, as well as upregulation of pro-MMP2. MMP2 mRNA
was upregulated 1.7-fold by TSP-1 at 10 and 20 g/mL. GM6001, an MMP inhibitor, inhibited VSMC migration
across the matrix barrier, whereas migration that occurred in the absence of the matrix barrier was unaffected. With a
binding assay, TSP-1 interacted physically with MMP2, and TSP-1–bound MMP2 showed the strongest binding activity
in comparison with collagen I, fibronectin, and elastin.
Conclusion: TSP-1 induced MMP2 activation through transcriptional and posttranslational mechanisms. These findings
imply that MMP2 activation is relevant to the mechanism of TSP-1–induced VSMC migration. (J Vasc Surg 2003;38:
147-54.)
Vascular smooth muscle cell (VSMC) migration con-
tributes to development of vascular pathologic states,
including intimal hyperplasia and atherosclerotic plaque
formation. Matrix metalloproteinases (MMPs) are a family
of zinc-dependent enzymes that are able to digest a wide
range of extracellular matrix (ECM) proteins, which are
contributory to certain processes, eg, during develop-
ment,1 vasculitis,2 and after vascular injury.3,4 More than
20 members of the MMP family exist.5 More well-known
MMP family members include collagenases (MMP1),
which degrade structural types I, II, and III collagen;
stromelysins (MMP3), which have a broad substrate
specificity; and type IV collagenases, also called gelati-
nases (MMP2, MMP9). Increasing evidence exists that
expression and activation of MMP2 are associated with
VSMC migration and proliferation in vitro.6,7
Thrombospondin-1 (TSP-1), a matricellular glycop-
rotein chemotactic for VSMCs, is not integral to arterial
wall structure but is expressed locally after acute arterial
injury, in atherosclerotic plaque, and in early intimal
hyperplasia.8,9 TSP-1 contains a number of binding sites
that have been implicated in interactions with more than
30 cell-surface and matrix proteins, including structural
proteins, cell surface receptors, enzymes, and cyto-
kines.10 TSP-1 has been implicated in a number of
biologic processes, including cell migration, coagula-
tion, cell adhesion, cell growth, modulation of cell-cell
and cell-matrix interactions, tumor growth and metasta-
ses, and angiogenesis, because of its ability to interact
with such a wide variety of proteins.11,12
Cell-matrix interactions likely have a substantial
role in regulation of cellular proteolysis. Various reports
have emphasized involvement of ECM components,
including fibronectin, bone matrix proteins such as
osteopontin, and type I collagen, in induction of
pro-MMP2 activation.13,14 As MMP2 and TSP-1 are
involved in VSMC migration, a process associated
with development of vascular lesions, we sought to de-
termine whether TSP-1 modulates MMP2 activation in
vitro and whether TSP-1–induced migration depends on
MMP2.
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VSMC culture. Bovine aortic VSMCs were isolated
and seeded in 10% fetal bovine serum (FBS; Hyclone,
Logan, Utah) and 1% antibiotic (Gibco BRL, Gaithers-
burg, Md) in primary culture.11 Subconfluent monolayers
of VSMCs in early passage (2-5) were used for each exper-
iment. In all experiments, cells were quiescent in serum-
free medium (SFM; Dulbecco modified Eagle medium
[DMEM]; Gibco BRL) for 48 hours.
Materials. Purified TSP-1, derived from human plate-
lets, was generously provided by Jack Lawler, PhD, Beth
Israel Deaconess Medical Center, Boston, Mass. The con-
centration of TSP-1 used for all invasion and chemotaxis
experiments was 20 g/mL), the peak concentration for
cell migration.15 Matrigel (BD Bioscience, Bedford, Mass),
GM 6001 (Chemicon, Temecula, Calif), purified pro-
MMP2 (Calbiochem, La Jolla, Calif), and anti-MMP2
antibodies (MMP2[2C1] mouse, monoclonal IgG1 spe-
cific for MMP2; Santa Cruz, Santa Cruz, Calif) were pur-
chased.
Chemotaxis and invasion assay. VSMC invasion was
investigated with a modified Boyden chamber (Neuro-
Probe, Gaithersburg, MD). Polyvinylidene floride (PVDF)
filters were coated with a layer of the reconstituted base-
ment membrane (Matrigel; 500 g/mL). Lower wells
were filled with SFM or 10% FBS containing 0.1% bovine
serum albumin (BSA), and coated filters were mounted in
the chamber. VSMCs (5  105), suspended in SFM or
TSP-1 (20 g/mL), were placed in the upper well and
allowed to settle on the coated filters. After 4 or 18 hours
(37°C) the membrane was fixed in 70% ethanol and stained
with hematoxylin. VSMCs that migrated to the bottom
side of the membrane were counted for 5 high-power fields
(HPF;, 400) per well. Each experiment was performed in
triplicate. The membrane was left uncoated for chemotaxis
experiments.
Northern blot analysis. Total cellular RNA was ex-
tracted from TSP-1–stimulated VSMCs with TRIzol re-
agent (Life Technology, Carlsbad, Calif) in accord with the
manufacturer’s instructions. RNA concentration was deter-
mined with a spectrophotometer. Ten micrograms or 15
g of total RNA was denatured in sample buffer (20
mmol/L 3-morpholinopropane sulfonic acid, 6% formal-
dehyde, 50% formamide), electrophoresed through a 1%
agarose-formaldehyde gel, and then transferred to a nylon
membrane (Boehringer Mannheim, Indianapolis, Ind) by
capillary transfer with 10 SSC. Hybridization was per-
formed with probes constructed from the human MMP2
cDNA, labeled with a random priming Oligolabelling Kit
(Amersham Bioscience, Piscataway, NJ) with [32P]-deoxy-
cytidine monophosphate (dCTP) and purified on Seph-
adex-G50 columns (Boehringer Mannheim). Blots were
washed twice with 1 SSC, 0.1% SDS (25°C), 0.1 SSC,
and 0.1% SDS (65°C), and then were exposed for several
hours or as necessary. Blots were stripped and reprobed
with a glyceraldehyde 3-phosphate dehydrogenase probe
(American Type Culture Collection, Manassas, Va) to stan-
dardize for RNA loading.
TSP-1 binding. Microtiter plates (BD Bioscience)
were coated overnight by passive adsorption at 4°C in assay
buffer (100 mmol/L of Tris-HCl [pH 7.5], 100 mmol/L
of NaCl, 10 mmol/L of CaCl2, 0.05% Brij-35) containing
100 g of the indicated matrix protein, as described.16
Nonspecific binding sites on coated wells were blocked by
incubation with a 200 mL volume of 3% BSA in assay buffer
for 2 hours (37°C). To evaluate activity of TSP-1–bound
MMP2, purified MMP2 (1 mmol/L) was activated with 2
mmol/L of amino-phenylmercuric acetate (APMA) for 30
minutes (37°C), diluted to 50 nmol/L in assay buffer, and
incubated overnight (4°C) in the selected matrix protein
(BSA, TSP-1, type I collagen, fibronectin, or elastin)–
coated wells in a 50 L volume. Aliquots (5 mL) were
removed and analyzed with gelatin substrate zymography
(designated “soluble phase”). Wells were then washed five
times with 50 L of assay buffer, and the bound enzyme
was eluted with two different techniques, one using nonre-
ducing Laemmli sample buffer (50 L for 1 hour at 25°C,
designated “bound”) and analyzed with gelatin zymogra-
phy, and the other using reducing Laemmli sample buffer
(50 g, designated “bound”) and analyzed with Western
blot. For the zymography analysis, the presence of bound
MMP2 was confirmed by incubating wells overnight at 4°C
with 10% dimethyl sulfoxide (DMSO) to disrupt MMP2-
ECM protein interactions.17
Western blot analysis. Proteins were separated with
sodium dodecylsulfate–polyacrylamide gel electrophoresis
(SDS-PAGE; 10% polyacrylamide) and transferred to a
nylon membrane (Amersham, Arlington Heights, Ill).
Blocking was performed in a 5% non-fat milk–tris-buffered
saline solution–Tween-20 (TBST) solution. Blots were in-
cubated in a 5% non-fat milk-TBST solution with anti-
MMP2 (Santa Cruz).
Gelatin zymography. Conditioned media were sub-
jected to electrophoresis in 10% SDS-PAGE containing 1
mg/mL of gelatin under nonreducing conditions, as de-
scribed.14 After electrophoresis, the gels were washed with
2.5% Triton X-100 to remove SDS and incubated for 48
hours at 37°C in 50 mmol/L of Tris buffer containing 200
nmol/L of NaCl and 20 mmol/L of CaCl2, pH 7.4. The
gels were stained with 0.5% Coomasie brilliant blue R-250
in 10% acetic acid and 45% methanol, and were destained.
Statistical analysis. All studies were performed in
triplicate. Blots were quantified with densitometry with
Un-Scan-It Software (Silk Scientific, Orem, Utah). The
data were analyzed with a paired t test (SigmaStat; SPSS
Science, Chicago, Ill) for chemotaxis, invasion, and densi-
tometry studies. P  0.05 was considered significant.
Experimental design
Three general types of experiments were performed:
static culture experiments, invasion assays, and binding
assays.
Static culture experiments. These experiments were
performed to look for MMP2 activation by TSP-1 without
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a basement membrane substrate. In the first experiment,
VSMC monolayer cultures on uncoated plates were ex-
posed to TSP-1 for 1, 4, or 24 hours. The resultant condi-
tioned media were analyzed with gelatin zymography. In
the second experiment, VSMC monolayer cultures on un-
coated plates were exposed to TSP-1 for 1, 4, or 24 hours.
To specifically show upregulation by TSP-1 of steady-state
mRNA for MMP2, the cells were used for Northern blot
analysis. To determine whether TSP-1 concentration was
important for MMP2 mRNA upregulation, 10 and 20
g/mL concentrations were used, as well as SFM (negative
control) and 10 ng/mL platelet-derived growth factor
(PDGF-BB, positive control, 1-hour exposure time).
Invasion assays. In assay 1, membranes were coated
with Matrigel. TSP-1, SFM (negative control), or tumor
necrosis factor- (TNF; positive control) was in the top
chamber, with VSMCs and 10% FBS in the bottom cham-
ber. The assay was run for 18 hours. In assay 2, the medium
from the top chamber in invasion assay 1 was used for
activation experiments with gelatin zymography. In assay 3,
to distinguish the importance of MMPs in invasion (pene-
tration of basement membrane) versus chemotaxis, inva-
sion assays (Matrigel-coated membrane) and chemotaxis
experiments (uncoated membrane) were performed with
the MMP inhibitor GM6001. This assay was run for only 4
hours, a standard time for running chemotaxis assays.
Binding assays. The purpose of these experiments was
to demonstrate whether activated MMP2 is bound to
TSP-1 and whether the degree of binding is similar or
different from that of other ECM proteins. First, plates
were coated with BSA, TSP-1, or type I collagen. Activated
MMP2 was added, incubated for 24 hours, and soluble and
bound protein was retrieved and used for both gelatin
zymography and Western blot analysis. Second, after dem-
onstrating that activated MMP2 binds TSP-1, TSP-1 was
compared with elastin, collagen I, and fibronectin. Bound
protein was retrieved, and comparisons were made with
gelatin zymography.
RESULTS
TSP-1 upregulates pro-MMP2. To investigate the
role of MMP2 in TSP-1–mediated VSMC migration, the
effect of TSP-1 on MMP2 production was determined. In
the resultant conditioned media, analyzed with gelatin
zymography, the SFM group showed increased production
of 72 kDa pro-MMP2, which was time-dependent (Fig 1).
TSP-1 induced more pro-MMP2 activation at 1 and 4
hours in comparison with SFM. MMP9 was not expressed.
TSP-1 increases MMP2 activation during VSMC inva-
sion. Invasion assays were performed to identify whether
the migratory activity of TSP-1–stimulated VSMCs
through a matrix protein substrate is regulated by gelati-
nase activity. After 18 hours, media in the top chamber
showed MMP2 activation in the TSP-1 and TSP-1/TNF-
groups (Fig 2, A). A small amount of 72 kDa pro-MMP2
was noted in these two groups as well. Lighter bands noted
between 59 and 72 kDa likely represent intermediate forms
of MMP2. This finding is consistent with other stud-
ies.18,19 TSP-1, with or without TNF-, showed more
migration than did SFM through the Matrigel-coated
membrane toward 10% FBS (TSP-1, 156  5.8 cells/5
HPF [SEM]; TSP-1/TNF-, 167 7.5; SFM, 46 9.1;
P .05; Fig 2, B). TSP-1, with or without TNF-, showed
a similar amount of cell migration. These results suggest
that TSP-1 could modulate MMP2 activity during VSMC
migration.
TSP-1 increases MMP2 mRNA levels. More pro-
MMP2 was expressed in the conditioned media of VSMCs
with TSP-1 when compared with SFM (Fig 1). To examine
this mechanism, MMP2 mRNA was measured in VSMCs
after exposure to TSP-1 for 1 hour. TSP-1 (10 or 20
g/mL) and the positive control, platelet-derived growth
factor BB (PDGF-BB), induced MMP2 mRNA expression
(1.7 0.29; P .05; Fig 3, A, B). MMP2 gene activation
to TSP-1 was time-dependent (Fig 3, C).
MMPs are required for TSP-1–induced VSMC che-
moinvasiveness. The hypothesis that MMPs are impor-
tant in TSP-1–induced VSMC invasion through a matrix
barrier was tested with Matrigel-coated membranes. With
the MMP inhibitor (GM6001), the effective role of MMPs
in the invasive activity of these cells was demonstrated.
Invasion was abolished by using GM6001 with TSP-1–
treated cells (66.67  2.6 vs 17.67  2.96 cells/5 HPF
[SEM]; P  .0075; Figs 4 and 5, A). GM6001 did not
affect the cells morphologically (Fig 4). Placing GM6001
in the bottom well did not inhibit TSP-1–induced chemo-
invasiveness. No change was noted in chemotaxis of
VSMCs with or without the MMP inhibitor when an
uncoated membrane was used (Fig 5, B). These results
Fig 1. TSP-1 upregulates pro-MMP2. VSMCs were seeded in plates and cultured in 10% FBS for 48 hours, then
incubated for 24 hours in SFM. Subsequently, the medium was changed with SFM with or without TSP-1 (20
g/mL). At indicated time points (1, 4, 24 hours), 30 L aliquots were collected and analyzed with gelatin
zymography. TSP-1 induced more pro-MMP2 activation at 1 and 4 hours compared with their respective negative
controls.
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suggest a specific role for MMP2 in cell-matrix barrier
invasion by TSP-1–stimulated VSMCs.
TSP-1 binds MMP2. To evaluate the role of TSP-1
binding in regulation of MMP2 activity, interaction of
MMP2 and TSP-1 was studied. Microtiter plates coated
with BSA (negative control), TSP-1, or type I collagen
(positive control) were incubated with MMP2 overnight,
and qualitative analysis of matrix-bound MMP2 was dem-
onstrated with gelatin zymography (Fig 6, A) and Western
blot (Fig 6, B). Active MMP2 was bound to TSP-1 and type
I collagen–coated wells, but not in BSA-coated control
samples.
TSP-1 preferentially binds MMP2 over other ECM
proteins. The relative catalytic activity of bound MMP2 was
assessed for TSP-1, elastin, type I collagen, and fibronectin.
With zymography there was more catalytic activity by
TSP-1 than the other proteins studied (Fig 7). This finding
suggests that TSP-1 is a specific matrix protein to induce
MMP2 activation.
DISCUSSION
Migration of VSMCs and remodeling of ECM are
significant events in development of intimal hyperplasia and
atherosclerosis.6 TSP-1 is an ECM protein, relevant to
different important processes, eg, vessel remodeling after
acute arterial injury, and in development of atherosclerotic
plaque and intimal hyperplasia.20 MMP2 is an important
protein for VSMC migration by ECM remodeling and is
activated in balloon catheter arterial injury lesions.21,22
Therefore we hypothesized that TSP-1 can modulate
MMP2 activity during VSMC invasion or cell migration
with penetration of the basement membrane by VSMCs.
No established information is available for MMP2 and
TSP-1 for VSMCs, although several conflicting reports
exist regarding the interaction between MMP2 and TSP-1
in endothelial cells undergoing angiogenesis.23,24
First, MMPs are relevant for TSP-1–induced VSMC
invasion. TSP-1–stimulated VSMCs could invade a Matri-
gel-coated filter as they migrated toward the chemoattrac-
tant 10% FBS. A significant number of cells adhered to the
Matrigel-coated filters and migrated to the underside of the
membrane in the direction of the chemoattractant. The
invasive ability of these VSMCs was reduced significantly
when MMP activity was inhibited with GM6001. This
inhibition was specific for cell invasion, inasmuch as che-
motaxis induced by TSP-1 was unaffected by GM6001.
The major gelatinase expressed in vitro by VSMCs in
response to the multifunctional matricellular protein TSP-1
was MMP2. MMP2 was present in TSP-1–conditioned
media in both the latent (pro-MMP2) and activated
(MMP2) forms. MMP2 expression is highly regulated by
environmental factors, and it also digests a number of
Fig 2. TSP-1 increases MMP2 activation during VSMC invasion. A, A modified Boyden chamber was used. The
porous membrane separating the two chambers was coated with Matrigel. VSMCs were stimulated with TSP-1 (20
g/mL) or TSP-1 with TNF- (10 ng/mL) in the upper well (18 hours) and 10% FBS in the lower well
(chemoattractant). Zymography demonstrated gelatinolytic activity of MMP2 in media obtained from the upper well
in the TSP-1 with or without TNF- groups. B, Findings are summarized for a representative invasion assay (N  3).
TSP-1 with or without TNF- induced more invasion than SFM alone (P  .05). No significant difference was noted
between TSP-1 and TSP-1 with TNF-. *P .05 in comparison with negative control (SFM).
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matrix proteins, including fibronectin, laminin, and colla-
gen type V.25 MMP2 is different from other MMPs, and it
is unaffected by a number of physiologic stimulators. For
example, a number of endopeptidases that stimulate
MMP1 and MMP3 do not activate MMP2.25
One reason why MMP2 may be activated by TSP-1
relates to the interaction between TSP-1 and transforming
growth factor-1 (TGF-1). Previous studies reported that
TGF-1 regulates MMP2 expression at the transcription
and posttranscription levels by inducing early increase in
MMP2 transcription and increase in the half-life of MMP2
mRNA.26 Data by other investigators indicate that TSP-1
can bind and is an important regulator for activation of
TGF-1.
27-29 We speculate that MMP2 activation by TSP-1
may be due to the indirect effect of TGF-1 activation.
Like many MMPs, MMP2 is secreted as a latent proen-
zyme, pro-MMP2, and must be activated extracellularly.
The cellular mechanism for pro-MMP2 activation is com-
plicated and must be controlled carefully, and activation
occurs only during certain processes, eg, cell migration or
invasion. Activation of secreted pro-MMP2 occurs at the
cell surface by way of formation of a ternary complex
between pro-MMP2, tissue inhibitor of metalloprotein-
ase-2 (TIMP-2), and a transmembrane MMP designated
membrane type I MMP (MT1-MMP).30,31 Active MMP2
undergoes concentration-dependent autolysis, which re-
sults in cleavage of the hemopexin-like domain from the
catalytic domain.32 This observation suggests that the ac-
tive state of MMP2 is unstable in the absence of substrate
and indicates that autolytic inactivation may function as an
alternative mechanism for the posttranslational control
mechanism of MMP2 activity. For example, type I and type
IV collagen promoted MMP2 activation in a dose-depen-
dent manner through stabilization of MMP2 against an
autolytic mechanism.16,33 The role of TIMP-2 and MT1-
MMP in TSP-1–induced MMP2 activation in VSMCs has
not been defined and will be studied in our laboratory.
TSP-1 activates MMP2 in VSMCs. MMP2–TSP-1 in-
teractions were evaluated to determine whether MMP2
binding to TSP-1 serves as a positive regulator of MMP2
Fig 3. TSP-1 increases MMP2 mRNA levels. A, Representative Northern blot demonstrates that after 1 hour of
exposure TSP-1 (10 and 20 g/mL) and PDGF-BB (10 ng/mL) induce upregulation of MMP2 steady-state mRNA.
B, Densitometric analysis of three independent experiments demonstrates that upregulation of MMP2 steady-state
mRNA occurred in groups exposed to TSP-1 (10 or 20 g/mL) or PDGF-BB (10 ng/mL). There was no significant
difference for degree of upregulation by the three groups in comparison with SFM alone. *P .05 in comparison with
negative control (SFM). C, Representative Northern blot indicates that TSP-1–induced upregulation of MMP2 mRNA
increases over the times measured (1, 4, 24 hours).
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activation. The results showed that MMP2 was detected in
TSP-1–coated plates. This finding is consistent with other
reports that TSP-1 interacts directly with MMP2.23,34 Fur-
thermore, in comparison with other ECM proteins studied,
ie, type I collagen, fibronectin (structural glycoprotein),
and elastin, TSP-1–bound MMP2 showed elevated activity
Fig 4. GM6001 inhibits TSP-1–induced VSMC invasion of membrane. A, TSP-1–stimulated VSMCs (5; 105),
suspended in DMEM containing 0.1% BSA, were added to upper chamber. Migrated VSMCs through Matrigel were
stained with hematoxylin (200). B, GM6001 (MMP inhibitor)–pretreated VSMCs were used instead in upper
chamber. Fewer cells migrated in the GM 6001–pretreated group.
Fig 5. MMPs are required for TSP-1–induced chemoinvasiveness, not chemotaxis. Bar graphs show effect of
GM6001 on chemoinvasion and chemotaxis of TSP-1–stimulated VSMCs. A, VSMCs with or without GM6001 were
placed in top chamber containing TSP-1. Bottom chamber contained 10% FBS with 0.1% BSA. Membrane separating
the two chambers was coated with Matrigel. Presence of GM6001 in the upper well prevented invasion of TSP-1–
stimulated VSMCs. GM6001 in the bottom chamber had no significant effect on invasion. *P .05 in comparison with
respective negative controls. B, Chemotaxis was measured in absence of a matrix barrier. MMP inhibition (GM6001)
did not affect VSMC chemotaxis.
JOURNAL OF VASCULAR SURGERY
July 2003152 Lee et al
at zymography. We speculate that TSP-1 has a stronger
affinity than the other matrix proteins for MMP2, which
might affect autolytic inactivation of MMP2.
In summary, TSP-1 induces MMP2 activity through
transcriptional or posttranslational mechanisms that are
related intimately to VSMC invasion. Results of this study
suggest that MMP2 activation is relevant to VSMC inva-
sion, an important in vivo process in development of vas-
cular lesions. This study establishes a preliminary relation-
ship between TSP-1 and MMP2. Future studies should
define which receptor site or sites of TSP-1 for VSMCs are
responsible for activation of MMP2; determine the role of
MT-1-MMP and TIMP2; and determine whether the ef-
fect of TSP-1 on MMP2 activation is the result of increased
activation or, to some extent, decreased autolysis of acti-
vated MMP2.
REFERENCES
1. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori
EN, Lark MW, et al. Cytokine-stimulated human vascular smooth
muscle cells synthesize a complement of enzymes required for extracel-
lular matrix digestion. Circ Res 1994;75:181-9.
2. Esparza J, Vilardell C, Calvo J, Juan M, Vives J, Urbano-Marquez A, et
al. Fibronectin upregulates gelatinase B (MMP-9) and induces coordi-
nated expression of gelatinase A (MMP-2) and its activator MT1-MMP
(MMP-14) by human T lymphocyte cell lines: a process repressed
through RAS/MAP kinase signaling pathways. Blood 1999;94:2754-
66.
3. Zempo N, Kenagy RD, Au YP, Bendeck M, Clowes MM, Reidy MA,
Clowes AW. Matrix metalloproteinases of vascular wall cells are in-
creased in balloon-injured rat carotid artery. J Vasc Surg 1994;20:209-
17.
4. Johnson JL, van Eys GJ, Angelini GD, George SJ. Injury induces
dedifferentiation of smooth muscle cells and increased matrix-degrad-
ing metalloproteinase activity in human saphenous vein. Arterioscler
Thromb Vasc Biol 2001;21:1146-51.
5. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem
1999;274:21491-4.
6. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos
N, et al. Migration of cultured vascular smooth muscle cells through a
basement membrane barrier requires type IV collagenase activity and is
inhibited by cellular differentiation. Circ Res 1994;75:41-54.
7. Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM.
Doxycycline modulates smooth muscle cell growth, migration, and
matrix remodeling after arterial injury. Am J Pathol 2002;160:1089-95.
8. Reed MJ, Iruela-Arispe L, O’Brien ER, Truong T, LaBell T, Bornstein
P, et al. Expression of thrombospondins by endothelial cells: injury is
correlated with TSP-1. Am J Pathol 1995;147:1068-80.
9. Roth JJ, Gahtan V, Brown JL, Gerhard C, Swami VK, Rothman VL, et
al. Thrombospondin-1 is elevated with both intimal hyperplasia and
hypercholesterolemia. J Surg Res 1998;74:11-6.
10. Bornstein P. Diversity of function is inherent in matricellular proteins:
an appraisal of thrombospondin 1. J Cell Biol 1995;130:503-6.
Fig 6. TSP-1 binds MMP2. MMP2 (50 nmol/L) was pretreated with amino-phenylmercuric acetate and incubated
overnight (4oC) in wells coated with BSA, TSP-1, or type I collagen (positive control, 50 g). Soluble enzyme was
removed (designated “soluble”). After washing wells with assay buffer, bound enzyme was eluted with two different
techniques: bound enzyme was eluted with nonreducing Laemmli sample buffer (50 g, designated “bound”) and
analyzed with gelatin zymography; and bound enzyme was eluted with reducing Laemmli sample buffer (50 g,
designated “bound”) and analyzed with Western blot. Both techniques demonstrated that TSP-1 binds MMP2. BSA,
TSP-1, and type I collagen upregulated pro-MMP2 and MMP2 when analyzing the soluble forms.
Fig 7. TSP-1 preferentially binds MMP2. To quantify activity of MMP2 bound to ECM proteins, MMP2 (10
nmol/L) was incubated overnight (4oC) in wells coated with BSA, TSP-1, elastin, type 1 collagen, or fibronectin. After
analysis, MMP2 was eluted with reducing Laemmli sample buffer (50 g, designated “bound”) and analyzed with
gelatin zymography. TSP-1 had a stronger binding affinity for MMP2 than did other ECM proteins studied.
JOURNAL OF VASCULAR SURGERY
Volume 38, Number 1 Lee et al 153
11. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix
interactions: SPARC, tenascin, and thrombospondin. J Biol Chem
1991;266:14831-4.
12. Sager R. Tumor suppressor genes: the puzzle and the promise. Science
1989;246:1406-12.
13. Sang QX, Thompson EW, Grant D, Stetler-Stevenson WG, Byers SW.
Soluble laminin and arginine-glycine-aspartic acid containing peptides
differentially regulate type IV collagenase messenger RNA, activation,
and localization in testicular cell culture. Biol Reprod 1991;45:387-94.
14. Seltzer JL, Lee AY, Akers KT, Sudbeck B, Southon EA, Wayner EA, et
al. Activation of 72-kDa type IV collagenase/gelatinase by normal
fibroblasts in collagen lattices is mediated by integrin receptors but is
not related to lattice contraction. Exp Cell Res 1994;213:365-74.
15. Gahtan V, Wang XJ, Willis AI, Tuszynski GP, Sumpio BE. Throm-
bospondin-1 regulation of smooth muscle cell chemotaxis is extracellu-
lar signal-regulated protein kinases 1/2 dependent. Surgery 1999;126:
203-7.
16. Ellerbroek SM, Wu YI, Stack MS. Type I collagen stabilization of matrix
metalloproteinase-2. Arch Biochem Biophys 2001;390:51-6.
17. Steffensen B, Wallon UM, Overall CM. Extracellular matrix binding
properties of recombinant fibronectin type II–like modules of human
72-kDa gelatinase/type IV collagenase: high affinity binding to native
type I collagen but not native type IV collagen. J Biol Chem 1995;270:
11555-66.
18. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, et al.
Intermolecular autolytic cleavage can contribute to the activation of
progelatinase A by cell membranes. J Biol Chem 1995;270:30479-85.
19. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay
between type I collagen and cell surface matrix metalloproteinase
activity. J Biol Chem 2001;276:24833-42.
20. Lawler J. The functions of thrombospondin-1 and	2. Curr Opin Cell
Biol 2000;12:634-40.
21. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth
muscle cell migration and matrix metalloproteinase expression after
arterial injury in the rat. Circ Res 1994;75:539-45.
22. Bassiouny HS, Song RH, Hong XF, Singh A, Kocharyan H, Glagov S.
Flow regulation of 72-kD collagenase IV (MMP-2) after experimental
arterial injury. Circulation 1998;98:157-63.
23. Bein K, Simons M. Thrombospondin type 1 repeats interact with matrix
metalloproteinase 2: regulation of metalloproteinase activity. J Biol
Chem 2000;275:32167-73.
24. Taraboletti GML, Donnini S, Parenti A, Granger HJ, Giavazzi R, Ziche
M. The heparin binding 25 kDa fragment of thrombospondin-1 pro-
motes angiogenesis and modulates gelatinase and TIMP-2 production
in endothelial cells. FASEB J 2000;10.1096.
25. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, et
al. Matrix metalloproteinase 2 from human rheumatoid synovial fibro-
blasts: purification and activation of the precursor and enzymic proper-
ties. Eur J Biochem 1990;194:721-30.
26. Overall CM, Wrana JL, Sodek J. Transcriptional and post-transcrip-
tional regulation of 72-kDa gelatinase/type IV collagenase by trans-
forming growth factor-beta 1 in human fibroblasts: comparisons with
collagenase and tissue inhibitor of matrix metalloproteinase gene ex-
pression. J Biol Chem 1991;266:14064-71.
27. Murphy-Ullrich JE, Schultz-Cherry S, Hook M. Transforming growth
factor-beta complexes with thrombospondin. Mol Biol Cell 1992;3:
181-8.
28. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich
JE. The activation sequence of thrombospondin-1 interacts with the
latency-associated peptide to regulate activation of latent transforming
growth factor-beta. J Biol Chem 1999;274:13586-93.
29. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J,
Hynes RO, et al. Thrombospondin-1 is a major activator of TGF-beta1
in vivo. Cell 1998;93:1159-70.
30. Itoh Y, Ito A, Iwata K, Tanzawa K, Mori Y, Nagase H. Plasma
membrane–bound tissue inhibitor of metalloproteinases (TIMP)–2
specifically inhibits matrix metalloproteinase-2 (gelatinase A) activated
on the cell surface. J Biol Chem 1998;273:24360-7.
31. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS,
et al. The TIMP2 membrane type 1 metalloproteinase “receptor”
regulates the concentration and efficient activation of progelatinase A: a
kinetic study. J Biol Chem 1998;273:871-80.
32. Bergmann U, Tuuttila A, Stetler-Stevenson WG, Tryggvason K. Auto-
lytic activation of recombinant human 72 kilodalton type IV collage-
nase. Biochemistry 1995;34:2819-25.
33. Maquoi E, Frankenne F, Noel A, Krell HW, Grams F, Foidart JM. Type
IV collagen induces matrix metalloproteinase 2 activation in HT1080
fibrosarcoma cells. Exp Cell Res 2000;261:348-59.
34. Yang Z, Kyriakides TR, Bornstein P. Matricellular proteins as modula-
tors of cell-matrix interactions: adhesive defect in thrombospondin
2-null fibroblasts is a consequence of increased levels of matrix metal-
loproteinase-2. Mol Biol Cell 2000;11:3353-64.
Submitted Aug 20, 2002; accepted Dec 2, 2002.
The JVS Ombudsman
The ombudsman’s role is to act as an advocate for authors and represent their position to the editorial staff in
relation to the process of manuscript submission, review, and publication. The ombudsman is not responsible for
evaluating the content of a manuscript or determining whether the editors made the correct decision with regard to
acceptance or rejection of the paper. If an author or other person has an unresolved complaint or question about the
editorial process of the Journal, he or she should contact Dr James S. T. Yao (Northwestern University Medical
School, Department of Surgery, 201 E. Huron Street, Suite 10-105, Chicago, IL 60611), who will review the matter.
JOURNAL OF VASCULAR SURGERY
July 2003154 Lee et al
